Member Info for Jace86

This dead cat could be dropped off the shard and it won't bounce again. No matter how much the pumpers try and ramp it up.

If you definitely will get the funds back just be aware of the spread. You will lose out regardless if you are planning to sell and then rebuy. The fastest option but would come with a fee is if you have a credit card. Cash to your account for zero percent interest if you have that type of offer but then you take a fee of around 1 to 3 percent of the overall cash transfer and then immediately pay it off once you get the funds back from Get Stocks. Risk is though if they go under whilst they have your funds because then it's trying to get it back off an insolvency firm. Client money should be ring-fenced but it's then how long they take to find what's yours and give it back. I personally use Hargreaves Lansdown. Platform is quite good and its reliable. Plus the size of the firm and volume of users will see it stay afloat.

I think it was the lack of good news and then the need for the fundraise. People new to this share like me though should see the corner it's turned. Those cautious may look to invest when news comes about from one of the many pieces that we are waiting on.

Cheers doubleheadedcoin! And yes, the low volume is a clear illustration of stability.

If everything remains on track the loan should start getting serviced soon too out of the profits of the Envia plant. I notice you post on alot of boards Dave, do you know just how much of Envia we hold in shares? And is that reflected at all in our current market cap?

Well how long will it take RR to assemble their plans and then give Velocys the nod if we are still their intended partner? As soon as that news comes in I'm confident this will fly. Then when other news that we are waiting for comes this should just snowball. Wouldn't surprise me if we see over 100 this year. It's the past disappointment that may leave people wary but I believe they have turned a corner.

At least it's not abandon ship and sell all shares... news of cash incoming and how much the company is earning off the RINs, as that's where the monetary value is and we know the value per gallon but need to see it for every 6 months as contracted then we will see some action with the share price.

40p would be for starters given the other news pieces that this company is waiting on... jimzi - who was your comment aimed at?

... is worth a look for those looking for information on this share too.

A-2-b - the placebo would be a completely null injection. The only drug available is benlysta. Both lupuzor and placebo patients got standard of care. Steroids + assessments I believe. lupus patients are known to flare up and down too. So if there's no trend pulled from the data this will be the presumption as to why some went into remission. IE it occurred naturally.

You mean those that would be classed as non responders for having dropped out?

Masterinvestors - if this is true then statistically they cannot amend the over all results but only identify a sub group that it may have done better on. Then explore from there. If they publish another RNS to imply that the first was wrong then they will be liable for covering investor losses.

Same. Would love to see the SP back where it was 3 years ago or perhaps beyond if some of these deals go on to create more. Be particularly ideal if the jet fuel deal sees an increase by way of budget air liners jumping on board if BA sees savings off the back of it.

Guessing people are impatient and not willing to wait for what sounds like imminent news...

Didnt we all believe before this point that results were to be fantastic and we'd be seeing billion + revenues? Better waiting until some official news comes via a registration of significant interest rather than putting into what is a coin flip!

Thanks Masterinvestors

There isnt one as far as I know. They have to speak to the regulators to discuss the way forward (if any) and then submit their NDA. Then there will be a review by the FDA.

A coin toss on a 10 bagger? A coin toss is a 50/50 so how can it be better?

https://www.sharesmagazine.co.uk/news/shares/immupharma-crashes-85-as-phase-iii-lupus-trials-flop Courtesy of Panure Gordon. Foot of the page.

Slip? Expect it to drop by a third without good news. 22p is out there in the media saying without speculation that's all this thing is worth.